Safety of propafenone application in patients with organic myocardial pathology at the prehospital stage

Abstract

In the course of the study, a group of patients with paroxysms of atrial fibrillation and organic myocardial pathology was identified, who were treated with the antiarrhythmic 1C class propafenone at the pre-hospital stage to control the rhythm. The effect of propafenone on hemodynamics in patients with and without organic myocardial pathology was compared.